Pfizer Raises FY2026 Adj EPS Guidance from $2.80-$3.00 to $2.95-$3.05 vs $2.96 Est; Raises FY2026 Sales Guidance from $60.500B-$62.500B to $62.000B-$64.000B vs $62.166B Est
Benzinga Newsdesk 3 days ago
NewsGuidanceHot
Pfizer (NYSE:PFE) raises FY2026 Adj EPS guidance from $2.80-$3.00 to $2.95-$3.05 vs $2.96 analyst estimate. Raises FY2026 sales outlook from $60.500 billion-$62.500 billion to $62.000 billion-$64.000 billion vs $62.166
Pfizer (NYSE:PFE) raises FY2026 Adj EPS guidance from $2.80-$3.00 to $2.95-$3.05 vs $2.96 analyst estimate. Raises FY2026 sales outlook from $60.500 billion-$62.500 billion to $62.000 billion-$64.000 billion vs $62.166 billion estimate.